Search research articles
Contact Us
Filters
Showing results (461-470 of 510) with videos related to
Page
of 51
Sort By:
Yonsei Medical Journal
|
May 24, 2001
Long-term outcome of kidney transplantation in adult recipients with focal segmental glomerulosclerosis
K H Choi, S I Kim, S Y Yoon, et al.
American Journal of Otolaryngology
|
September 24, 2014
Pharyngocutaneous fistula after total laryngectomy: a single-institution experience, 2001-2012
Eleni M Benson, Richard M Hirata, Carol B Thompson, et al.
The Laryngoscope
|
January 3, 2026
Perineural Invasion and Survival in Pembrolizumab-Treated Head and Neck Squamous Cell Carcinoma
Angeline A Truong, Savinnie Ho, Rex H Lee, et al.
Head & Neck
|
May 10, 2026
Neutrophil-To-Lymphocyte Ratio and Survival in Pembrolizumab-Treated Oropharyngeal Cancer
Angeline A Truong, Savinnie Ho, Rex H Lee, et al.
Cancers
|
January 21, 2023
Patterns of Postoperative Trismus Following Mandibulectomy and Fibula Free Flap Reconstruction
Rex H Lee, Cara Evans, Joey Laus, et al.
Cancer
|
February 28, 2017
The prognostic role of sex, race, and human papillomavirus in oropharyngeal and nonoropharyngeal head and neck squamous cell cancer
Carole Fakhry, William H Westra, Steven J Wang, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery
|
December 15, 2024
Neutrophil-to-Lymphocyte Ratio and Pembrolizumab Outcomes in Oral Cavity Squamous Cell Carcinoma
Angeline A Truong, Rex H Lee, Xin Wu, et al.
The Laryngoscope
|
March 29, 2019
Treatment modality impact on quality of life for human papillomavirus-associated oropharynx cancer
Mary Jue Xu, Karolina A Plonowska, Zev R Gurman, et al.
Head & Neck
|
January 20, 2011
Factors associated with pharyngoesophageal stricture in patients treated with concurrent chemotherapy and radiation therapy for oropharyngeal squamous cell carcinoma
Simon R Best, Patrick K Ha, Ray G Blanco, et al.
Cell Death and Differentiation
|
May 7, 2013
ZNF313 is a novel cell cycle activator with an E3 ligase activity inhibiting cellular senescence by destabilizing p21(WAF1.)
J Han, Y-L Kim, K-W Lee, et al.
Page
of 51
Search research articles
Search
Showing results (461-470 of 510) with videos related to
Sort By:
Page
of 51
Yonsei Medical Journal
|
May 24, 2001
Long-term outcome of kidney transplantation in adult recipients with focal segmental glomerulosclerosis
K H Choi, S I Kim, S Y Yoon, et al.
American Journal of Otolaryngology
|
September 24, 2014
Pharyngocutaneous fistula after total laryngectomy: a single-institution experience, 2001-2012
Eleni M Benson, Richard M Hirata, Carol B Thompson, et al.
The Laryngoscope
|
January 3, 2026
Perineural Invasion and Survival in Pembrolizumab-Treated Head and Neck Squamous Cell Carcinoma
Angeline A Truong, Savinnie Ho, Rex H Lee, et al.
Head & Neck
|
May 10, 2026
Neutrophil-To-Lymphocyte Ratio and Survival in Pembrolizumab-Treated Oropharyngeal Cancer
Angeline A Truong, Savinnie Ho, Rex H Lee, et al.
Cancers
|
January 21, 2023
Patterns of Postoperative Trismus Following Mandibulectomy and Fibula Free Flap Reconstruction
Rex H Lee, Cara Evans, Joey Laus, et al.
Cancer
|
February 28, 2017
The prognostic role of sex, race, and human papillomavirus in oropharyngeal and nonoropharyngeal head and neck squamous cell cancer
Carole Fakhry, William H Westra, Steven J Wang, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery
|
December 15, 2024
Neutrophil-to-Lymphocyte Ratio and Pembrolizumab Outcomes in Oral Cavity Squamous Cell Carcinoma
Angeline A Truong, Rex H Lee, Xin Wu, et al.
The Laryngoscope
|
March 29, 2019
Treatment modality impact on quality of life for human papillomavirus-associated oropharynx cancer
Mary Jue Xu, Karolina A Plonowska, Zev R Gurman, et al.
Head & Neck
|
January 20, 2011
Factors associated with pharyngoesophageal stricture in patients treated with concurrent chemotherapy and radiation therapy for oropharyngeal squamous cell carcinoma
Simon R Best, Patrick K Ha, Ray G Blanco, et al.
Cell Death and Differentiation
|
May 7, 2013
ZNF313 is a novel cell cycle activator with an E3 ligase activity inhibiting cellular senescence by destabilizing p21(WAF1.)
J Han, Y-L Kim, K-W Lee, et al.
Page
of 51